Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-26T02:34:28.850Z Has data issue: false hasContentIssue false

The prevalence of hepatitis B in Sweden; A statistical serosurvey of 3381 Swedish inhabitants

Published online by Cambridge University Press:  01 October 1997

B. CHRISTENSON
Affiliation:
Department of Communicable Disease Control and Prevention, Stockholm County Council, Karolinska Hospital, SE-171 76 Stockholm, Sweden
M. BÖTTIGER
Affiliation:
Swedish Institute for Infections Disease Control, SE-105 21 Stockholm, Sweden
L. GRILLNER
Affiliation:
Department of Clinical Microbiology, Karolinska Hospital, SE-171 76 Stockholm, Sweden
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The prevalence of hepatitis B virus markers in the adult Swedish population was investigated according to age, sex, origin and demographic stratum. Sera were collected from 3382 persons in 1990–1. The sera were selected on a statistical basis considered to be representative of the Swedish population from adults aged [les ]18 years. Two of the sera (0·06%) were found to be hepatitis B surface antigen positive. The two hepatitis B carriers were of non-Scandinavian origin as were (8·9%) of those tested. A total of 90 persons had a marker of previous, hepatitis B virus infection, i.e. antibodies against hepatitis B core antigen. Of these, 66 (2·0%) were of Scandinavian origin and 24 (18·1%) from highly endemic areas. The overall hepatitis B virus marker prevalence was 2·7%. The highest age-specific prevalence of hepatitis B markers in those of Scandinavian origin was in those born in 1939 and earlier. In this age-group, women had a significantly higher prevalence (3·6%) than males (1·9%). The lowest prevalence was found in those born in 1970 and later. No significant, age-related differences between younger or older persons, or between men and women, could be found in persons of non-Scandinavian origin. The results showed significant differences in exposure to hepatitis B virus among the indigenous population, compared with those of non-Scandinavian extraction. The results do not support the proposal to include hepatitis B vaccination in the Swedish immunization schedule.

Type
Research Article
Copyright
© 1997 Cambridge University Press